Hyperglycemia potentiates the effect of ionic calcium in photoreceptor ellipsoid zone disruption in diabetic retinopathy

. 2019 Oct ; 39 (10) : 2237-2243. [epub] 20190109

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid30628026
Odkazy

PubMed 30628026
DOI 10.1007/s10792-018-01063-8
PII: 10.1007/s10792-018-01063-8
Knihovny.cz E-zdroje

PURPOSE: To study the association of serum ionic calcium and glycated hemoglobin (HbA1c) with retinal photoreceptor ellipsoid zone (EZ) disruption in diabetic retinopathy (DR). METHODS: This is a tertiary care center-based observational cross-sectional study. Sixty-three consecutive cases, divided into 21 cases each with no diabetic retinopathy, non-proliferative diabetic retinopathy and proliferative diabetic retinopathy were included. Twenty-one healthy controls were also included. Ellipsoid zone disruption was assessed using spectral-domain optical coherence tomography. Serum ionic calcium and HbA1c were measured using standard protocol. Patient data from cases were divided into two groups according to their HbA1c levels: group 1 (HbA1c < 7, n = 26) and group 2 (HbA1c > 7, n = 37). Data were analyzed statistically. RESULTS: Mean ionic calcium levels in group 1 and group 2 were 1.131 ± 0.073 mmol/dL and 1.170 ± 0.070 mmol/dL, respectively. In group 1, 11 out of 26 had EZ disruption (42.3%). Similarly, in group 2, 29 out of 37 had EZ disruption (78.4%). On logistic regression analysis, as compared to group 1, ellipsoid zone disruption was found to be positively associated with serum ionic calcium (p = 0.01) in group 2 cases. CONCLUSION: Increased levels of serum ionic calcium are associated with increased EZ disruption in patients with HbA1c > 7 in DR.

Zobrazit více v PubMed

Brain Res. 1988 Mar 8;443(1-2):389-94 PubMed

Ophthalmology. 1991 May;98(5 Suppl):786-806 PubMed

Development. 2000 Apr;127(8):1641-9 PubMed

Hypertension. 1999 Sep;34(3):484-90 PubMed

Clin Ophthalmol. 2014 Dec 09;8:2507-22 PubMed

Diabetes Care. 2004 Mar;27(3):704-8 PubMed

Indian J Med Res. 2012 Jul;136(1):46-53 PubMed

Am J Ophthalmol. 2017 Sep;181:1-11 PubMed

Diabetes Care. 2013 Oct;36(10):3208-15 PubMed

Br J Ophthalmol. 1998 Aug;82(8):901-6 PubMed

Cell Calcium. 2010 Feb;47(2):130-9 PubMed

Clin Exp Ophthalmol. 2015 Jul;43(5):429-36 PubMed

Nat Med. 1999 Oct;5(10):1183-7 PubMed

Neuron. 1996 Aug;17(2):323-31 PubMed

J Diabetes Complications. 1997 Jan-Feb;11(1):27-34 PubMed

Front Biosci. 2002 Sep 01;7:d2023-44 PubMed

Invest Ophthalmol Vis Sci. 1980 Oct;19(10):1236-41 PubMed

Neuron. 1993 Oct;11(4):595-605 PubMed

Cell Calcium. 2011 Dec;50(6):523-9 PubMed

Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6145-52 PubMed

Am J Physiol Cell Physiol. 2009 Mar;296(3):C558-69 PubMed

BMJ. 2000 Aug 12;321(7258):405-12 PubMed

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1651-8 PubMed

Mol Vis. 2013 Aug 04;19:1760-8 PubMed

Ophthalmology. 2009 Feb;116(2):311-8 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...